July 12, 2014 4:54 PM ET

Pharmaceuticals

Company Overview of zuSyn, Inc.

Company Overview

zuSyn, Inc. engages in the development of anticancer drugs. It develops new drug candidates using its glycochemistry technology by modifying natural product scaffolds. The company was founded in 2004 and is based in Kalamazoo, Michigan. zuSyn, Inc. operates as a subsidiary of zuChem, Inc.

4717 Campus Drive

Suite 100

Kalamazoo, MI 49008

United States

Founded in 2004

Phone:

484-259-5005

Key Executives for zuSyn, Inc.

Chief Executive Officer
Age: 52
Chief Executive Officer of Southwest Michigan Innovation Center
Age: 68
Vice President of Research & Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Fontus Pharmaceuticals, Inc. United States
C.B. Fleet Company, Inc. United States
Phytomedics, Inc. United States
Confluence Life Sciences, Inc. United States
Ipsen Biopharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact zuSyn, Inc., please visit www.zusyn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.